Business
Statement re Online Commentary
Statement re Online Commentary.
About this update from Feedback Plc
[{"type":"text","content":"\n \nRNS Number : 2506I Feedback PLC 07 August 2019 \n\nThe information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain\n \nFeedback plc\nStatement re Online Commentary \nCambridge, 7 August 2019: Feedback plc (AIM: FDBK, \"Feedback\" or the \"Company\"), the specialist medical imaging technology company, notes the recent online commentary regarding a proposed equity fundraising by the Company. \nThe Company confirms that, in order to develop BleepaTM, the Company's clinical messaging product, it is currently working on completing a placing of new shares. There can be no certainty that such fundraising will be concluded nor as to the timing or terms of such, but a further announcement will be made as required as soon as possible.\n-Ends-\nEnquiries: \n\n\n\nFeedback plc\nTom Oakley, CEO\nLindsay Melvin, CFO\n \n\n\n+44 (0)1954 718072\[email protected]\n\n\n\n\nAllenby Capital Limited (Nominated Adviser)\nDavid Worlidge / Asha Chotai\n \n\n\n+44 (0)20 3328 5656\n\n\n\n\nPeterhouse Capital Ltd (Joint Broker)\nLucy Williams / Duncan Vasey\n \n\n\n+44 (0)20 7469 0936\n\n\n\n\nStanford Capital Partners Limited (Joint Broker)\nPatrick Claridge / John Howes\n \nInstinctif Partners\nRozi Morris/ Deborah Bell/ Phillip Marriage\n\n\n+44 20 3815 8880\n \n \n+44 (0)20 7457 2020\[email protected]\n\n\n\n \nNotes to editors\nAbout Feedback plc\nFeedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). For more information, see www.fbk.com\n \n\nThis info...